Purchase Order 75N92E21P00096
Award Date 3/4/21
Potential Completion Date 6/30/22
Potential Value $20K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,000 purchase order to Illumina, Inc. to provide DRAGEN CS LVL 1 LICENSE THROUGHPUT OF 100,000GB under contract number E21C6L5011010032. The one-year contract, which runs from July 2025 through July 2026, calls for Illumina to deliver genomic sequencing software licensing and throughput on a firm fixed price basis, to be billed quarterly in arrears. As the prime...
- This federal contract award, valued at $15,000.00, was issued by the National Human Genome Research Institute (NHGRI) to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a DRAGEN CS Level 1 License with a throughput of 100,000GB, with a period of performance from July 25, 2024 to July 24, 2025. The contract is a firm fixed price purchase order and does not have a set-aside designation. Illumina has previously received prime federal...
- This firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the provision of a DRAGEN Appliance for HIVE. The total potential value of the contract is $210,454.80, with a completion date of September 21, 2024. Illumina has a history of providing sequencing instruments, consumables, and support services to various federal agencies, including the...
- This firm-fixed-price purchase order was awarded by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Illumina, Inc. The contract is for a DRAGEN GCP Level 4 Service License to enable NIDA's Neurodegenerative Diseases Research Section to process high-quality genome data from 10,000 patients with neurodegenerative diseases. The DRAGEN platform performs optimized algorithms for alignment, variant calling, and other advanced genomic analyses....
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,613.88 firm fixed price delivery order to Illumina, Inc. under contract number QTE# 00015178.1. The place of performance will be Illumina's facilities located in San Diego, California. The period of performance is July 31, 2023 for genomic sequencing and analysis services to support the Institute's research efforts aimed at advancing the understanding of the human...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $22,984.57 firm fixed price delivery order to Illumina, Inc. of San Diego, California. The order is to provide genomics products and services to support the agency's genome research efforts. No major subcontractors or set aside designations were identified. This award draws from the Multiple Award Schedule contract vehicle to procure needed goods and services for the NIH's...
- The Department of Health and Human Services Food and Drug Administration awarded a firm fixed price purchase order to Illumina, Inc. for a DRAGEN Appliance for HIVE, including the license, platform, installation, and support plan. The contract has a potential value of $255,450.00 and a completion date of August 28, 2024. Illumina, a manufacturer of goods, has previously received prime federal contracts and subcontracts from agencies such as the National Institutes of Health, Centers for...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $219,211.97 firm fixed price delivery order to Illumina, Inc., a manufacturer of genomic sequencing and analysis instruments and reagents. The order is not set-aside and was awarded on September 19, 2019, with a completion date of September 2, 2020. Illumina has a history of providing sequencing systems, consumables, and services to support genomic research and diagnostics...
- The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $10,856.27 firm fixed price delivery order to Illumina, Inc. for goods and services to support genomic sequencing and analysis. As the sole manufacturer of the sequencing instruments in use, Illumina will provide reagents, consumables and other supplies under the delivery order citing its proprietary technology. The place of performance is the agency's location in...
- This firm fixed price purchase order was awarded to Illumina, Inc. by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), for the deployment of two Illumina DRAGEN Server v4 systems and associated licenses. The total ceiling value of the contract is $200,500.00, with a period of performance through October 26, 2025. The original solicitation indicates that the NCI requires the DRAGEN processors to support its Whole Genome and Whole Exome Data Processing...